Table 1.

Characteristics of Selected Participants at Baseline (Childhood [Aged 5–12 yr]) (N = 682)

Age, yr	8.7 (2.0)
Sex, M	59.8
Ethnicity
White	67.7
Black	15.2
Hispanic	9.2
Other	7.8
Body mass index percentile	66th (28th)
Duration of asthma, yr	4.7 (2.6)
Age at symptom onset, yr	3.2 (2.5)
Age at M.D. diagnosis, yr	4.0 (2.6)
At least one positive skin test	87.4
Sensitized and exposed* to indoor allergens	81.7
Eczema	28.9
Hay fever	52.6
Food allergy	18.0
Parental asthma	43.1
Treatment group assignment in CAMP†
Budesonide	29.8
Nedocromil	29.6
Placebo	40.6

Definition of abbreviations: CAMP = Childhood Asthma Management Program; M.D. = Doctor of Medicine.

Data are presented as a percentage or as the mean (SD).

^*The criteria for significant allergen exposure are as follows: cat allergen concentration >8,000 ng/g or cat allowed inside the home; dog allergen concentration >10,000 ng/g or dog allowed inside the home; mite allergen concentration >2,000 ng/g; cockroach allergen concentration >2 U/g or cockroaches in the home; and >25,000 mold colonies or mold on any surface of the home.

^†Refers to original treatment group assignment from the Childhood Asthma Management Program Research Group (see Reference 15).